Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples